In a 17-center, 300-patient randomized study comparing CardioNet MCOT™ with LOOP event monitors, CardioNet proved to be nearly 3x* superior to LOOP event monitors at detecting clinically significant arrhythmias.

  • CardioNet proven to be nearly 3x superior to LOOP event monitors at detecting clinically significant Atrial Fibrillation in all patients 23% vs. 8% (p<0.001); In the same group of patients, CardioNet detected asymptomatic Atrial Fibrillation 17% vs. 0% in LOOP event monitors (p<0.001)
  • In patients with syncope or presyncope, CardioNet proven greater than 3x superior to LOOP event monitors for detecting clinically significant arrhythmias 52% vs. 16% (p<0.001)
  • In patients with syncope or presyncope, CardioNet proven greater than 3x superior to LOOP event monitors for detecting Afib/Aflutter 24% vs. 2% (p<0.001); In the same group of patients, CardioNet detected asymptomatic Atrial Fibrillation 19% vs. 0% in LOOP event monitors
  • In all patients, an arrhythmia was confirmed or excluded as the primary cause of the symptom in 88% of CardioNet patients vs. 75% LOOP patients (p=0.008).
*The results of this study were published online early at the Journal of Cardiovascular Electrophysiology (JCE) on January 8, 2007. The results were published in print in the March 2007 issue of JCE, Vol. 18, No. 3.

Click here to download a copy of the complete study.

Study Title

"The Diagnosis of Cardiac Arrhythmias: A Prospective Multi-Center Randomized Study Comparing Mobile Cardiac Outpatient Telemetry versus Standard Loop Event Monitoring"

Journal/Publication Date

Journal of Cardiovascular Electrophysiology, Volume 18, No. 3, March 2007, Pg 1-7. Published online at the Journal of Cardiovascular Electrophysiology website January 8, 2007.

Study Design

17-center, 300-patient randomized study comparing the relative value of CardioNet Mobile Cardiac Outpatient Telemetry (MCOT) system with a patient-activated external looping event monitor (LOOP) for symptoms (palpitations, syncope, and/or presyncope) thought to be due to an arrhythmia.

Patient Inclusion Criteria
  • High clinical suspicion of a malignant arrhythmia
  • Symptoms of syncope, presyncope, or severe palpitations less frequently than once per 24 hours
  • A non-diagnostic 24-hour Holter or telemetry monitor within 45 days prior to enrollment in study
Primary Endpoint

Confirmation or exclusion of a probable arrhythmic cause of patient's symptoms

© CardioNet , All Rights Reserved, A BioTelemetry, Inc. Company privacy policy/terms site map contact us info@cardionet.com